TARO PHARMACEUTICAL INDS LTD shareholders Q3 2023

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

TARO PHARMACEUTICAL INDS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Citadel Advisors 22,666$854,7340.00%
Nuveen Asset Management, LLC 21,603$814,6490.00%
Lindbrook Capital, LLC 38$1,4330.00%
Tower Research Capital LLC (TRC) 309$11,6520.00%
Harel Insurance Investments & Financial Services Ltd. 564$210.00%
Allspring Global Investments Holdings, LLC 1,728$65,1620.00%
CWM, LLC 4$00.00%
JPMORGAN CHASE & CO 6,413$241,8350.00%
Farther Finance Advisors, LLC 7$2640.00%
BARCLAYS PLC 4,822$1830.00%
ROYAL BANK OF CANADA 2,026$76,0000.00%
D. E. Shaw & Co., Inc. 9,978$376,2700.00%
VANGUARD GROUP INC 48,052$1,812,0410.00%
RHUMBLINE ADVISERS 9,756$367,8900.00%
BNP PARIBAS FINANCIAL MARKETS 1,230$46,3830.00%
OSAIC HOLDINGS, INC. 363$13,6880.00%
FMR LLC 480$18,1000.00%
US BANCORP \DE\ 1,276$48,1180.00%
Parallel Advisors, LLC 22$8300.00%
BANK OF AMERICA CORP /DE/ 11,047$416,5820.00%
External links

This page lists TARO PHARMACEUTICAL INDS LTD's shareholders in Q3 2023. To view TARO PHARMACEUTICAL INDS LTD's shareholder history, click here.